3Higgins G. Hits and misses in treating diabetic complications:partⅡ [J ]. Inpharma, 1996,1045: 3 - 16.
4Serri O. Somatostatin analogue, octreotide, reduces increased glomerularfiltration rate and kidney size in insulin-dependent diabetes[J ]. JAMA, 1991,265(20) :888 - 892.
5Griggs J, Skepper JN, Smith GA, et al. Inhibition of proliferative retino pathy by the anti-vascular agent combretastatin-A4 [ J ].Am J Pathol,2002,160(3): 1097 - 1103.
6Xia P, Aiello LP, Ishii H, et al. Characterization of vascula rendothelial growth factor'sef-fect on the activation of proteinkinase C, its isoform in myocardi-umcause cardiomypathy [ J ]. J Clin Invest, 1996,98(9) :2018 - 2026.
7Koya D, LeeI K, Ishii H, et al. Prevention of glomeruler dysfunction in diabetic rats by treatment with d-a-tocophrcol[J]. J Am Soc Nephrol, 1997,8(3) :426 - 435.
8Kunisaki M, Bursells E, Clermont AC, et al. Vitamin E prevents diabeties-inducedabnormal retinalblook flow via the diacylglycerol protein kinease C pathway[J]. Am J Phsiol, 1995, 269 (8):E239 - E246.
9山口喜久二.应用蜂王浆治疗糖尿病并发症[J].蜜蜂杂志,2000,8:26-26.
10Kiho T,Hui J,Yamanc A, et al.Polysaccharides in fungi,Hypoglycemic activity of polysaccharide (CS- F30) form the cultural mycelium of cordyceps sinensis and its effect on glucose metabolism in mouse live[J]. Biol pharm Bull, 1996, 19(2):294 - 296.
